For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241118:nRSR4950Ma&default-theme=true
RNS Number : 4950M Ovoca Bio PLC 18 November 2024
Ovoca Bio plc
("Ovoca" or the "Company")
Notice of AGM
Dublin, Ireland, November 18, 2024 - Ovoca Bio, a biopharmaceutical company
with a focus on women's health, announces that it has posted the Notice of
Annual General Meeting ("AGM") to shareholders.
The AGM is convened to be held at Buswells Hotel, 23-27 Molesworth Street,
Dublin 2, Ireland on Wednesday 18(th) December 2024 at 3.00 p.m. The Notice of
AGM contains details of all resolutions to be proposed at the AGM.
Copies of the Notice of AGM will also shortly be available on the Company's
website, www.ovocabio.com (http://www.ovocabio.com) .
End
For further information:
Ovoca Bio plc
Tim McCutcheon (Chief Executive Officer)
Tel +353 1 661 9819
info@ovocabio.com
Davy (Nominated Adviser, Euronext Growth Listing Sponsor and Broker)
Ivan Murphy / Daragh O'Reilly
Tel: +353 1 679 6363
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NOAMZMMMVKDGDZM